Limited participation of 5-HT(1A) and 5-HT(2A/2C) receptors in the clozapine-induced Fos-protein expression in rat forebrain regions

European Journal of Pharmacology

Volumn 408, Issue 1, 2000, Pages 11-17

  Sebens, Jantiena B ^a   Kuipers, Sjoukje D ^a   Koch, Tineke ^a   Ter Horst, Gert J ^a   Korf, Jakob ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

8 OH DPAT; Clozapine; DOI; Fos protein; Tolerance

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; CLOZAPINE; CORTICOSTERONE; PROTEIN; PROTEIN FOS; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

AMYGDALOID NUCLEUS; ANIMAL TISSUE; ARTICLE; CORPUS STRIATUM; DRUG TOLERANCE; FOREBRAIN; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; THALAMUS MIDLINE NUCLEUS; TISSUE DISTRIBUTION;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; AMPHETAMINES; ANIMALS; ANTIPSYCHOTIC AGENTS; CLOZAPINE; CORTICOSTERONE; IMMUNOHISTOCHEMISTRY; MALE; ONCOGENE PROTEINS V-FOS; PROSENCEPHALON; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTOR, SEROTONIN, 5-HT2C; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN AGONISTS;

EID: 0034634385     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00670-1     Document Type: Article

References (34)

1. Synthesis of n.c.a. carbon-11 labelled clozapine and its major metabolite clozapine-N-oxide and comparison of their biodistribution in mice
2. Radioreceptor binding profile of the atypical antipsychotic olanzapine
3. In vitro and in vivo biochemistry of olanzapine: A novel, atypical antipsychotic drug
4. 3 dopamine receptor-deficient mice
5. 5-HT(1A) receptor agonist flesinoxan enhances Fos immunoreactivity in rat central amygdala, bed nucleus of the stria terminalis and hypothalamus
6. Pretreatment with 5-HT(1A) receptor agonist flesinoxan attenuates Fos protein in rat hypothalamus
7. Biochemical and behavioural properties of clozapine
8. High-performance liquid chromatographic (HPLC) separation and quantitation of endogenous glucocorticoids after solid-phase extraction from plasma
9. The effects of antipsychotic drugs on Fos protein expression in the prefrontal cortex: Cellular localization and pharmacological characterization
10. Stress selectivity increases fos protein in dopamine neurons innervating the prefrontal cortex
11. D(2) dopamine receptor antagonists induce Fos and related proteins in rat striatal neurons
12. 2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects
13. The effect of clozapine on Fos protein immunoreactivity in the rat forebrain is not mimicked by the addition of α(1)-adrenergic or 5HT(2) receptor blockade to haloperidol
14. Serotonin receptor subtypes involved in the elevation of serum corticosterone concentration in rats by direct and indirect-acting serotonin agonists
15. Motor and mental side effects of clozapine
16. Serotonin-dopamine interaction and its relevance to schizophrenia
17. On the unique profile of action of clozapine as assessed with fos-protein induction in rat brain regions
18. Chronic clozapine treatment decreases 5-hydroxytryptamine(1C) receptor density in the rat choroid plexus: Comparison with haloperidol
19. Serotonin(2/1C) receptor activation causes a localized expression of the immediate-early gene c-fos in rat brain: Evidence for involvement of dorsal raphe nucleus projection fibres
20. Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: Role of 5HT2 receptors
21. The role of serotonin in antipsychotic drug action
22. Dopaminergic and serotonergic effects of clozapine. Implications for a unique clinical profile
23. Melperone and clozapine: Neuroendocrine effects of atypical neuroleptic drugs
24. Paradoxical effects of lithium on serotonergic receptor function: An immunocytochemical, behaviourly and autoradiographic study
25. Decreased histamine H1 receptors in the frontal cortex of brains from patients with chronic schizophrenia
26. Involvement of adenosine A(2A) receptors in the induction of c-fos expression by clozapine and haloperidol
27. Neuroleptics increase c-fos expression in the forebrain: Contrasting effects of haloperidol and clozapine
28. Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity
29. Fenfluramine-induced activation of the immediate-early gene c-fos in the striatum: Possible interaction between serotonin and dopamine
30. Differential Fos-protein induction in rat forebrain regions after acute and long-term haloperidol and clozapine treatment
31. Lack of cross-tolerance between haloperidol and clozapine towards Fos-protein induction in rat forebrain regions
32. Olanzapine-induced Fos expression in the rat forebrain; cross-tolerance with haloperidol and clozapine
33. c-fos mRNA, Fos, and Fos-related antigen induction by hypertonic saline and stress
34. Modification of haloperidol-induced pattern of c-fos expression by serotonin agonists